Keywords: nexstar, ambisome, gets, new, indication, approval, liposomal

NexStar'a Ambisome gets new indication approval

Article | 29 January 1996

- NexStar's Ambisome (liposomal amphotericin B) has been approved for the first-line therapy of systemic fungal infections with Candida, Aspergillus and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Amphotericin B

Ambisome

Abelcet

Fungizone

Go to drug listing